Skip to content
10-Q

Quarterly Report

NOVADEL PHARMA INC

0001193125-11-220566

← back to feed
Filed
Aug 12, 2011 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2011 · Aug 4, 2011 134.69M sh
Operating Cash Flow Q2 2011 · Jun 30, 2011 −$1.41M
Operating Cash Flow Q2 2011 · Jun 30, 2010 −$1.06M
Cash And Equivalents Q2 2011 · Jun 30, 2011 $865K
Cash And Equivalents Q2 2011 · Dec 31, 2010 $900K
Cash And Equivalents Q2 2011 · Jun 30, 2010 $3.12M
Cash And Equivalents Q2 2011 · Dec 31, 2009 $2.66M
Stockholders Equity Q2 2011 · Jun 30, 2011 −$9.68M
Stockholders Equity Q2 2011 · Dec 31, 2010 −$5.84M
Current Liabilities Q2 2011 · Jun 30, 2011 $4.31M
Current Liabilities Q2 2011 · Dec 31, 2010 $4.37M
Total Liabilities Q2 2011 · Jun 30, 2011 $10.87M
Total Liabilities Q2 2011 · Dec 31, 2010 $8.06M
Current Assets Q2 2011 · Jun 30, 2011 $1.02M
Current Assets Q2 2011 · Dec 31, 2010 $1.99M
Total Assets Q2 2011 · Jun 30, 2011 $1.2M
Total Assets Q2 2011 · Dec 31, 2010 $2.22M
Sga Expense Q2 2011 · Jun 30, 2011 $703K
Sga Expense Q2 2011 · Jun 30, 2011 $1.39M
Sga Expense Q2 2011 · Jun 30, 2010 $813K
Sga Expense Q2 2011 · Jun 30, 2010 $1.79M
Rd Expense Q2 2011 · Jun 30, 2011 $412K
Rd Expense Q2 2011 · Jun 30, 2011 $1.03M
Rd Expense Q2 2011 · Jun 30, 2010 $559K
Rd Expense Q2 2011 · Jun 30, 2010 $1.01M
Net Income Q2 2011 · Jun 30, 2011 −$5.02M
Net Income Q2 2011 · Jun 30, 2011 −$7.6M
Net Income Q2 2011 · Jun 30, 2010 −$1.13M
Net Income Q2 2011 · Jun 30, 2010 −$2.42M
Operating Income Q2 2011 · Jun 30, 2011 −$923K
Operating Income Q2 2011 · Jun 30, 2011 −$2.16M
Operating Income Q2 2011 · Jun 30, 2010 −$1.31M
Operating Income Q2 2011 · Jun 30, 2010 −$2.6M
Revenue Q2 2011 · Jun 30, 2011 $192K
Revenue Q2 2011 · Jun 30, 2011 $257K
Revenue Q2 2011 · Jun 30, 2010 $66K
Revenue Q2 2011 · Jun 30, 2010 $195K